Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Bullboard Posts
Comment by love_minus_zeroon Feb 19, 2011 9:09am
292 Views
Post# 18163334

RE: General meeting proposition

RE: General meeting proposition

Immo, very good post.
I understand that a buy back is probably not in the cards, but a tiny one if implemented daily might be quite meaningful in support of the SP...but it is probably not in the cards. The speculation on a secondary, has, and is, just that. No one knows...at least not officially.

TH management needs to move smartly forward. It is highly possible that a listing on Nasdaq will happen but that could be later this year or next...and I would support that, including the required secondary with the listing.

There needs to be better communication at TH with the outside world.

If TH were to go for more than one indication, and go as quickly as possible, it might require doing a PP even without listing on Nasdaq. Patents dont last forever...I know this because I have one (and have applied for another)...so maximizing the time frame of the patent is a big part of the game.

Every day should matter.

Every single day.

Not always sure this is what we get with TH.

But I am an optimist.

lmz

ps thanks for posting in English as well...dont speak French...

ps2 Everything that Socrates wrote is Greek to me!

Bullboard Posts